Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Chinook Therapeutics Inc (KDNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2023	03-2023	12-2022	09-2022	06-2022
Assets
Current Assets
Cash & Cash Equivalents	127,149	118,495	115,438	126,072	145,927
Marketable Securities	170,016	231,881	262,887	247,211	216,687
Receivables	3,102	2,444	1,091	2,919	3,115
TOTAL	$305,417	$358,644	$385,592	$381,670	$371,399

Non-Current Assets
PPE Net	16,235	16,974	16,908	16,827	17,500
Investments And Advances	47,956	50,855	52,260	70,730	89,132
Intangibles	60,088	60,521	60,954	61,387	61,818
Other Non-Current Assets	59,115	56,881	58,370	59,722	61,393
TOTAL	$183,394	$185,231	$188,492	$208,666	$229,843

Total Assets	$488,811	$543,875	$574,084	$590,336	$601,242

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	16,362	9,774	9,751	11,843	4,907
Accrued Expenses	29,342	33,605	33,636	25,583	17,373
Other current liabilities	2,500	2,500	2,500	2,500	2,500
TOTAL	$52,472	$50,964	$50,835	$44,736	$29,481

Non-Current Liabilities
Other Non-Current Liabilities	74,224	75,442	76,232	70,229	63,895
TOTAL	$79,300	$80,518	$81,308	$70,964	$64,630

Total Liabilities	$131,772	$131,482	$132,143	$115,700	$94,111

Shareholders' Equity
Shares Outstanding, K	71,805	66,889	65,846	63,941	62,896
Common Shares	7	7	7	6	6
Retained earnings	-546,752	-479,808	-419,631	-357,077	-301,098
Other shareholders' equity	-1,325	-1,711	-3,164	-3,623	-2,531
TOTAL	$357,039	$412,393	$441,941	$474,636	$507,131

Total Liabilities And Equity	$488,811	$543,875	$574,084	$590,336	$601,242